gearinjectuk.com
No products in the cart.
Return To Shopgearinjectuk.com
No products in the cart.
Return To ShopAmlip 10 mg, manufactured by Cipla, is a pharmaceutical product primarily utilized for the management of hypertension and angina pectoris. Amlodipine, the active ingredient, belongs to the class of dihydropyridine calcium channel blockers, which were first introduced in the late 1980s. The unique formulation of Amlip not only helps in reducing blood pressure but also facilitates better blood flow to the heart muscle, subsequently improving exercise capacity and reducing the risk of heart-related conditions.
In terms of composition, each tablet contains 10 mg of Amlodipine and is formulated with various excipients that enhance stability and bioavailability. Amlip’s efficacy in treating cardiovascular conditions has made it a staple in both general and sports pharmacology, as blood pressure management is crucial for athletic performance.
Upon ingestion, Amlodipine is quickly absorbed into the bloodstream, where it binds to calcium channels in vascular smooth muscle cells. By inhibiting calcium influx, Amlodipine causes vasodilation, resulting in wider blood vessels and improved circulation. This reduction in vascular resistance leads to a decrease in blood pressure, allowing the heart to work more efficiently.
In athletes, optimal cardiovascular performance is essential. Amlip may assist with exercise tolerance by increasing oxygen supply to the muscles during physical stress. Furthermore, this vasodilatory effect can enhance recovery times, making it a valuable tool for those engaged in rigorous training regimens.
To acquire Amlip 10 mg Cipla, it is advisable first to consult a healthcare professional who will evaluate your specific health needs and determine if this medication is suitable for you. Once prescribed, Amlip can be purchased through pharmacies or online platforms that supply authentic pharmaceutical products.
When purchasing online, ensure that you verify the legitimacy of the website. Look for certified pharmacies that require a prescription and offer customer support. Be cautious of counterfeit products, which can compromise health and treatment effectiveness. Always keep your medications in a cool, dry place away from direct sunlight and out of reach of children.
Amlip 10 mg Cipla is not suitable for everyone. Individuals with a history of hypersensitivity to Amlodipine or any of its components should avoid this medication. Additionally, patients with severe hypotension, aortic stenosis, or certain forms of heart failure should not use Amlip due to the potential for exacerbating these conditions. Pregnancy and lactation are also contraindications, as the safety of Amlodipine in these populations has not been adequately studied.
Amlip is beneficial for several key reasons, particularly in both general and sports contexts:
Overall, Amlip 10 mg Cipla can be an essential component of a comprehensive approach to cardiovascular health and athletic performance.
| Active substance | Amlodipine |
|---|---|
| Water Retention | Can cause mild water retention |
| Hepatotoxicity | Low risk |
| Lab Test | Not typically required |
| Strength | 10mg |
| Also known as | Norvasc |
| Blood pressure | Reduces blood pressure |
| Trade name | Norvasc, among others |
| Storage conditions | Store at room temperature away from moisture and light |
| Chemical name | 3-Ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Formula | C20H25ClN2O5 |
| Substance class | Calcium channel blocker |
| Main action | Vasodilator |
| Half-life | 30-50 hours |
| Dosage (medical) | Typically 5 mg once daily, may be increased to 10 mg depending on patient response |
| Dosage (sports) | Not applicable |
| Effects | Lowering blood pressure, increasing blood flow |
| Side effects | Headache, swelling, fatigue, abdominal pain, dizziness |
| Use in sports | Not typically used in sports |
| Manufacturer | Cipla Ltd. |
| Packing | 10 tabs/blister |
€75.00
€8.00
Reviews
There are no reviews yet.